Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth
- Resource Type
- Article
- Source
- In
Cancer Letters 28 March 2018 417:182-191 - Subject
- Language
- ISSN
- 0304-3835